CIK 0000872912 · Non-accelerated filer<br>Smaller reporting company
DELCATH SYSTEMS, INC.
Sign in to watch- Ticker
- DCTH
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061245881
- Phone
- (518) 743-8892
- Business address
- 566 QUEENSBURY AVENUE, QUEENSBURY, NY, 12804
- Former names
- DELCATH SYSTEMS, INC., DELCATH SYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $488,508
- in 1 filing
Net −$488,508. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-12 | John Johnny See Remarks | Grant or award · Stock Option (Right to Buy) | +59,813 | 59,813 | ||
| 2023-04-18 | Rosalind Advisors, Inc. Director | Other acquisition · Pre-Funded Warrant | +538,828 | $5.63 | $3.0M | 719,965 |
| 2023-03-29 | MICHEL GERARD J Chief Executive Officer | Purchase | +19,646 | $4.84 | $95K | 197,235 |
| 2023-03-29 | MICHEL GERARD J Chief Executive Officer | Purchase · Tranche A Warrants to Purchase Common Stock | +31,110 | $0.13 | $4K | 31,110 |
| 2023-03-29 | MICHEL GERARD J Chief Executive Officer | Purchase · Tranche B Warrants to Purchase Common Stock | +16,666 | $0.13 | $2K | 16,666 |
| 2023-02-08 | Dias Anthony VP FINANCE | Grant or award · Stock Option (Right to Buy) | +31,200 | 31,200 | ||
| 2023-02-08 | Muir Kevin VP COMMERCIAL OPERATIONS | Grant or award · Stock Option (Right to Buy) | +46,800 | 46,800 | ||
| 2023-02-08 | Hoffman David L. GEN'L COUNSEL, CCO & SECY | Grant or award · Stock Option (Right to Buy) | +46,800 | 46,800 | ||
| 2023-02-08 | Purpura John CHIEF OPERATING OFFICER | Grant or award · Stock Option (Right to Buy) | +56,160 | 56,160 | ||
| 2023-02-08 | John Johnny SVP CLINICAL DEV & MED AFFAIRS | Grant or award · Stock Option (Right to Buy) | +46,800 | 46,800 | ||
| 2023-02-08 | MICHEL GERARD J CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +140,400 | 140,400 | ||
| 2022-12-14 | Rosalind Advisors, Inc. Director | Purchase | +15,215 | $3.62 | $55K | 459,315 |
| 2022-12-14 | SALAMON STEVEN A J Director | Purchase | +15,215 | $3.62 | $55K | 455,315 |
| 2022-12-13 | Aharon Gil Director | Purchase · Pre-Funded Warrant | +692,042 | $2.89 | $2.0M | 1,258,793 |
| 2022-12-13 | Rosalind Advisors, Inc. Director | Purchase · Pre-Funded Warrant | +692,042 | $2.89 | $2.0M | 1,258,793 |
| 2022-12-13 | SALAMON STEVEN A J Director | Purchase · Pre-Funded Warrant | +692,042 | $2.89 | $2.0M | 1,258,793 |
| 2022-12-13 | MICHEL GERARD J Chief Executive Officer | Purchase | +51,725 | $2.90 | $150K | 177,589 |
| 2022-07-20 | MICHEL GERARD J Chief Executive Officer | Purchase | +62,814 | $3.98 | $250K | 125,864 |
Page 7 of 7 · 138 trades